[HTML][HTML] Potential role of tumor-derived exosomes in non-small-cell lung cancer in the era of immunotherapy

A Tartarone, R Lerose, M Tartarone, M Aieta - Life, 2022 - mdpi.com
Lung cancer, of which non-small-cell lung cancer (NSCLC) represents about 80% of all
cases, is the second most common cancer diagnosed in the general population and one of …

[HTML][HTML] The potential biomarkers and immunological effects of tumor-derived exosomes in lung cancer

SD Alipoor, E Mortaz, M Varahram… - Frontiers in …, 2018 - frontiersin.org
Lung cancer remains the leading cause of cancer-related deaths worldwide. Despite
considerable achievements in lung cancer diagnosis and treatment, the global control of the …

[HTML][HTML] The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications

H Zheng, Y Zhan, S Liu, J Lu, J Luo, J Feng… - Journal of Experimental & …, 2018 - Springer
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases,
and it is one of the leading causes of cancer death in both men and women worldwide due …

[HTML][HTML] Exosomes in the lung cancer microenvironment: Biological functions and potential use as clinical biomarkers

R Qi, Y Zhao, Q Guo, X Mi, M Cheng, W Hou… - Cancer Cell …, 2021 - Springer
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …

[HTML][HTML] Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer

Y Wu, H Fu, J Hao, Z Yang, X Qiao, Y Li… - Frontiers in …, 2024 - frontiersin.org
Exosomes play a crucial role in facilitating intercellular communication within organisms.
Emerging evidence indicates that a distinct variant of programmed cell death ligand-1 (PD …

[HTML][HTML] Tumor-derived exosomes: immune properties and clinical application in lung cancer

J Wu, S Li, P Zhang - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-related death worldwide. Despite advances in
diagnosis and treatment of lung cancer, the overall survival remains poor. Evidence …

[HTML][HTML] Progress of exosomes in the diagnosis and treatment of lung cancer

K Xu, C Zhang, T Du, ANA Gabriel, X Wang, X Li… - Biomedicine & …, 2021 - Elsevier
The incidence and mortality of lung cancer account for first place all over the world. Lung
cancer lacks early diagnostic biomarkers; lung cancer patients are usually diagnosed in …

Role of exosomes in lung cancer: A comprehensive insight from immunomodulation to theragnostic applications

FH Khan, MJ Reza, YF Shao, A Perwez, H Zahra… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Exosomes are 30 to 150 nm-diameter lipid bilayer-enclosed extracellular vesicles that
enable cell-to-cell communication through secretion and uptake. The exosomal cargoes …

The role and underlying mechanisms of tumour-derived exosomes in lung cancer metastasis

J He, L Yang, N Zhou, L Zu, S Xu - Current Opinion in Oncology, 2023 - journals.lww.com
The role and underlying mechanisms of tumour-derived exosome... : Current Opinion in
Oncology The role and underlying mechanisms of tumour-derived exosomes in lung cancer …

[HTML][HTML] Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis

MY Li, LZ Liu, M Dong - Molecular cancer, 2021 - Springer
Lung cancer is often diagnosed at an advanced stage and has a poor prognosis.
Conventional treatments are not effective for metastatic lung cancer therapy. Although some …